Product Image

Omega 3 Fish Oil Concentrate

Solgar
4.8
★ ★ ★ ★ ★
(25286 ratings)
Omega-3 600 mg
EPA (Eicosapentaenoic Acid) 320 mg
Fish Oil 2000 mg
DHA 200 mg
Product Image
Score84
Triglyceride form and efficient maintenance dosing are meaningful strengths. The modest concentration and missing source and quality-control details are the main limits.
How scoring works
Quantity:120 Softgel(s) • (60 servings)
Goals:
Skin Health
Vision Support
Anti-Inflammatory Support
Cardiovascular Support

Score 84

Triglyceride form and efficient maintenance dosing are meaningful strengths. The modest concentration and missing source and quality-control details are the main limits.
How scoring works
$11.99($0.19 per serving)
Pure Formulas
$ 13.49
Daily Vita
$ 14.84
iHerb
$ 11.99
Vitacost
$ 13.19
Report prices

Analysis

The serving provides 320 mg of EPA and 200 mg of DHA in a triglyceride-form oil. That form improves absorption confidence compared with an unspecified or ethyl ester product, although the total amount remains geared to maintenance.

Clear active quantities and an efficient serving cost make routine use practical. The supplied label does not name the fish species, antioxidant protection, or independent purity verification.

The formula works well for adults who want a reasonably absorbed, budget-friendly daily fish oil. Higher-intake cardiovascular, inflammatory, or DHA-focused goals would require a more concentrated serving.

Who is it for
  • Adults seeking triglyceride-form fish oil
  • Budget-conscious maintenance users
  • People wanting moderate EPA and DHA
Best for
  • Everyday omega-3 maintenance
  • Users who prioritize molecular form
  • Low-cost routine supplementation

Pros

  • Triglyceride form is identified
  • EPA and DHA amounts are clearly listed
  • Efficient serving cost
  • Provides a balanced maintenance profile

Cons

  • Active concentration is modest
  • Fish species is not disclosed
  • No antioxidant protection is listed
  • Independent purity verification is not supplied

Warnings

  • Contains fish oil and is not suitable for people with a fish allergy
  • Fish oil may cause fishy aftertaste, reflux, or digestive discomfort in sensitive users

Nutrient quality

83 Highest impact

Triglyceride-form fish-oil concentrate in softgels gives the formula reasonable ingredient quality. Dose uncertainty or limited delivery detail prevents a confident quality assessment.

Ingredient transparency

85 Highest impact

The meaningful actives and their amounts are clearly identified. Serving guidance and the complete inactive-ingredient list are not fully supplied.

Customer satisfaction

73 High impact

The aggregate rating is strong and supported by useful review volume. No review excerpts are supplied to assess repeated complaints or purpose-specific experiences.

Value for money

93 Highest impact

Formula quality provides fair value for the category. The effective serving and focused ingredient list compare favorably with similar options.

Report analysis

Goals

Skin Health
Impact
Highest effect
B+ Goal FitB+ Strength of SupportC CoverageA- Formula Quality
Omega-3 · 600 mg

EPA and DHA may support skin-barrier lipids and balanced inflammatory signaling. The combined active amount is useful, while the triglyceride form supports favorable absorption.

Separate EPA and DHA labeling improves dose clarity. Generic sourcing and missing antioxidant or independent purity details remain meaningful limitations.

Study evidence
Omega-3 Supportive 35 studies
Vision Support
Impact
High effect
B- Goal FitB Strength of SupportD+ CoverageA+ Formula Quality
EPA (Eicosapentaenoic Acid) · 320 mg

EPA and DHA provide useful support for ocular-surface balance and retinal membrane structure. Their moderate amounts create a focused lipid strategy rather than complete vision coverage.

The triglyceride form and individual fatty-acid quantities are clearly disclosed. No carotenoids, zinc, or antioxidant vitamins are included for complementary protection.

Study evidence
Anti-Inflammatory Support
Impact
High effect
A Goal FitC Strength of SupportD- CoverageA+ Formula Quality
Fish Oil · 2000 mg

EPA and DHA provide strong evidence for inflammation-resolving lipid pathways, but the combined 520 mg amount falls below the stated minimum. The fish-oil total is clearly listed, so the more important limitation is low active omega-3 concentration.

The focused formula avoids unrelated additions and supplies both key fatty acids. A higher EPA and DHA amount would provide better depth for systemic anti-inflammatory support.

Study evidence
Fish Oil Supportive 68 studies
Cardiovascular Support
Impact
High effect
B+ Goal FitC- Strength of SupportD CoverageB+ Formula Quality
Fish Oil · 2000 mg

EPA and DHA directly support triglyceride management and cardiovascular membrane function. Fish oil has strong human evidence for lowering triglycerides, although clinical benefit depends on dose and user context.

The combined EPA and DHA amount is modest for targeted cardiovascular effects. The triglyceride form supports absorption, but fish source, purification, and antioxidant protection are not disclosed.

Study evidence
Fish Oil Supportive 185 studies

Ingredients

IngredientAmount per serving
Calories
20 Calorie(s)
Total Fat
2 Gram(s)
Saturated Fat
0.5 Gram(s)
Polyunsaturated Fat
1 Gram(s)
Monounsaturated Fat
0.5 mg
Cholesterol
20 mg
Fish Oil concentrate
2000 mg
Total Omega-3 Polyunsaturates
600 mg
Eicosapentaenoic Acid
320 mg
Docosahexaenoic Acid
200 mg
Gluten Free Adults 18–50 Dairy Free Sugar Free
Report overview
Omega-3 · 600 mg OverallScore71
B- Active Ingredient Quality & BioavailabilityC- Dose, Safety & Label TransparencyA+ Value

The triglyceride form supports favorable absorption, and EPA and DHA are disclosed separately. Active fatty acids still make up only a modest share of the fish oil, while source detail, antioxidant protection, and independent testing are absent. A low serving cost provides excellent value per combined EPA and DHA amount.

C- Active Ingredient Quality & BioavailabilityC Dose, Safety & Label TransparencyA+ Value

An explicitly stated triglyceride form supports absorption; ePA density is low, and no protective antioxidant is listed. The serving provides a standard EPA amount with a clearly EPA-centric ratio. No purification or third-party verification is shown, while normalized cost is excellent.

Fish Oil · 2000 mg OverallScore53
D- Active Ingredient Quality & BioavailabilityF Dose, Safety & Label TransparencyA+ Value

Triglyceride form supports absorption, though purification and fish species are not disclosed. EPA and DHA are listed separately, but the combined amount and concentration are low. Cost efficiency is excellent, while antioxidant protection is not shown.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Dose-dependent effects of fish oil on cardio-metabolic biomarkers in healthy middle-aged and elderly Chinese people: a double-blind randomized controlled trial.
    Song J; Hu M; Li C; Yang B; Ding Q; Wang C; Mao L · Food & function · 2018
    Randomized trial201 participantsAnti-Inflammatory Support forFish Oil
  2. Eicosapentaenoic acid supplementation alleviates pruritus, enhances skin moisture, and mitigates depression in maintenance hemodialysis patients.
    Lin YL; Wang CL; Chiang TI · Frontiers in nephrology · 2024
    Randomized trial60 participantsAnti-Inflammatory Support forFish Oil
  3. Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: results from a randomized controlled trial.
    Yang B; Ren XL; Li ZH; Shi MQ; Ding F; Su KP; Guo XJ; Li D · Food & function · 2020
    Randomized trial77 participantsAnti-Inflammatory Support forFish Oil
  4. The effects of ω-3 fish oil emulsion-based parenteral nutrition plus combination treatment for acute paraquat poisoning.
    Meng Z; Dong Y; Gao H; Yao D; Gong Y; Meng Q; Zheng T; Cui X; Su X; Tian Y · The Journal of international medical research · 2019
    Randomized trial174 participantsAnti-Inflammatory Support forFish Oil
  5. Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Liu R; Jiang J; Fu Z; Liu C; Yao L; Quan H · Journal of the American Nutrition Association · 2022
    Meta-analysis49 studies pooledAnti-Inflammatory Support forFish Oil
  6. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
    Hu Y; Hu FB; Manson JE · Journal of the American Heart Association · 2020
    Meta-analysis127,477 participants13 studies pooledCardiovascular Support forFish Oil
  7. Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
    Lu J; Liu R; Ren H; Wang S; Hu C; Shi Z; Li M; Liu W; Wan Q; Su Q; Li Q; Zheng H; Qu S; Yang F; Ji H; Lin H; Qi H; Wu X; Wu K; Chen Y; Xu Y; Xu M; Wang T; Zheng J; Ning G; Zheng R; Bi Y; Zhong H; Wang W · Med (New York, N.Y.) · 2025
    Randomized trial309 participantsCardiovascular Support forFish Oil
  8. A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
    Campbell F; Dickinson HO; Critchley JA; Ford GA; Bradburn M · European journal of preventive cardiology · 2013
    Meta-analysis1,524 participants17 studies pooledCardiovascular Support forFish Oil
  9. Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
    Zeng Q; Dong SY; Liu YP; Fu J; Shuai P; Zhao ZM; Li TX · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2017
    Randomized trial422 participantsCardiovascular Support forFish Oil
  10. Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Sekikawa A; Cui C; Sugiyama D; Fabio A; Harris WS; Zhang X · Nutrients · 2020
    Meta-analysis6 studies pooledCardiovascular Support forFish Oil
  11. Dietetic intervention in psoriatic arthritis: the DIETA trial.
    Leite BF; Morimoto MA; Gomes CMF; Klemz BNC; Genaro PS; Shivappa N; Hébert JR; Damasceno NRT; Pinheiro MM · Advances in rheumatology (London, England) · 2022
    Randomized trial97 participantsSkin Health forOmega-3
  12. Omega-3 fatty acid supplement skin cancer prophylaxis in lung transplant recipients: A randomized, controlled pilot trial.
    Miura K; Vail A; Chambers D; Hopkins PM; Ferguson L; Grant M; Rhodes LE; Green AC · The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2019
    Randomized trial49 participantsSkin Health forOmega-3
  13. Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.
    Soleimani Z; Hashemdokht F; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z · Journal of diabetes and its complications · 2018
    Randomized trial60 participantsSkin Health forOmega-3
  14. Treatment of hard-to-heal wounds in ischaemic lower extremities with a novel fish skin-derived matrix.
    Lee YJ; Han HJ; Shim HS · Journal of wound care · 2024
    Randomized trial50 participantsSkin Health forOmega-3
  15. Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers.
    Rhodes LE; Shahbakhti H; Azurdia RM; Moison RM; Steenwinkel MJ; Homburg MI; Dean MP; McArdle F; Beijersbergen van Henegouwen GM; Epe B; Vink AA · Carcinogenesis · 2003
    Randomized trial42 participantsSkin Health forOmega-3
  16. Dietary omega-3 LCPUFA intake in the prevention of neovascular age-related macular degeneration: a systematic review and meta-analysis.
    Meng XT; Shi YY; Hong-Yan Z · Nutricion hospitalaria · 2022
    Meta-analysis5 studies pooledVision Support forEPA (Eicosapentaenoic Acid)
  17. Dietary omega-3 polyunsaturated fatty acids and fish intake and risk of age-related macular degeneration.
    Jiang H; Shi X; Fan Y; Wang D; Li B; Zhou J; Pei C; Ma L · Clinical nutrition (Edinburgh, Scotland) · 2022
    Meta-analysis21 studies pooledVision Support forEPA (Eicosapentaenoic Acid)
  18. Dietary fatty acid intake, plasma fatty acid levels, and the risk of age-related macular degeneration (AMD): a dose-response meta-analysis of prospective cohort studies.
    Zhong Y; Wang K; Jiang L; Wang J; Zhang X; Xu J; Yao K · European journal of nutrition · 2021
    Meta-analysis167,581 participants11 studies pooledVision Support forEPA (Eicosapentaenoic Acid)
  19. Dietary ω-3 fatty acid and fish intake and incident age-related macular degeneration in women.
    Christen WG; Schaumberg DA; Glynn RJ; Buring JE · Archives of ophthalmology (Chicago, Ill. : 1960) · 2011
    Cohort study38,022 participantsVision Support forEPA (Eicosapentaenoic Acid)
  20. Can Omega-3 Fatty Acids Serve as a Preventive Strategy for Age-Related Macular Degeneration? A Systematic Review and Meta-Analysis.
    Chen KY; Chan HC; Chan CM · The Journal of nutrition · 2026
    Meta-analysis18 studies pooledVision Support forEPA (Eicosapentaenoic Acid)